Granger Genetics, LLC performs high complexity laboratory testing in compliance with Clinical Laboratory Improvement Amendments (CLIA) and Joint Commission certifications. Our focus is clinical testing using biochemical and immunochemistry techniques and laboratory support of human clinical trials.
Our Mission
Our mission is to employ the most current technology to deliver accurate and reliable results for optimal diagnosis and patient care.
Our Leadership
David G. Bostwick, M.D., M.B.A.
CEO / Medical Director
Dr. David G. Bostwick was formerly Professor of Pathology and Urology at the Mayo Clinic (from 1991 to 1999), Dr. Bostwick founded Bostwick Laboratories in 1999, and it is now the leading urologic pathology practice in the US.
An internationally renowned urologic pathologist with more than 30 years of experience and interest in prostate cancer, bladder cancer and urologic diseases, Dr. Bostwick is the most sought-after pathologist for second opinions in urologic pathology. He has presented more than 2000 lectures around the world, is past President of the International Society of Urological Pathology, and currently serves on the editorial board of eight medical journals.
Dr. Bostwick has authored and edited 17 books, more than 30 book chapters and more than 500 professional papers. His book, Urologic Surgical Pathology (WB Saunders, 1997, 2007 and 2013) is the bestselling uropathology medical textbook. Other current best-sellers are his books American Cancer Society’s Complete Guide to Prostate Cancer (American Cancer Society, 2005) and Essentials of Pathology, 3rd Edition (Springer 2001, 2006, and 2011). His most quoted works include the first descriptions of prostatic intraepithelial neoplasia (1986) and atypical small acinar proliferation (1998).
Jason Duncan
Chief Scientific Officer
F Jason Duncan brings 27 years of experience in academic and industrial laboratory research. He earned a Ph.D. in Cancer Immunology from The Ohio State University and a bachelor’s degree in Biotechnology from James Madison University.
Dr. Duncan completed two postdoctoral fellowships at Nationwide Children’s Hospital in the field of gene therapy. His research explored treatments for lysosomal storage diseases and musculoskeletal disorders, contributing to IND-enabling studies for the former and advancing therapeutic development for the latter.
He later joined Advaxis to develop cancer immunotherapies using an attenuated Listeria monocytogenes vector. Prior to joining Granger Genetics, he spent eight years at PPD, now part of Thermo Fisher Scientific, where he led the development and validation of immunoassays for clinical trials. His work supported numerous clinical development programs, including studies that contributed to the global approval of Merck’s CAPVAXIVE®, the 21-valent pneumococcal conjugate vaccine.
“We are pleased to welcome Dr. F Jason Duncan to Granger Genetics as our new Chief Scientific Officer,” said Dr. Bostwick, CEO of Granger Genetics. “Dr. Duncan brings a proven record of strategic leadership and organizational vision that will be instrumental as we continue to strengthen our position and advance our long-term goals. We are confident his leadership will play a key role in driving Granger Genetics forward.”
“I am honored to join Granger Genetics as Chief Scientific Officer at such an exciting time in the company’s growth. I look forward to working alongside this exceptional team to expand our scientific capabilities, accelerate innovation, and develop new solutions that improve patient care and address complex challenges for our clinical, pharmaceutical, and commercial partners,” said Dr. Duncan.
Cindy Daniels
Chief Operating Officer
Cindy Daniels is a dynamic and accomplished professional with extensive experience in operations management, logistics, and customer service. She currently serves as the Chief Operating Officer at Granger Genetics, LLC, where she has demonstrated expertise in process improvement, strategic decision-making, regulatory compliance, and fostering a proactive team culture. Cindy has a proven track record of driving revenue growth, optimizing workflows, and managing cross-departmental collaboration.
Her career spans various roles in finance, customer service and logistics in the U.S. Army. She has developed strong skills in payroll administration, benefits administration, reporting and analyzing data, account auditing, and vendor management. Cindy is adept at financial analysis, contract negotiation, and compliance with regulations.
Her educational background includes training in logistics, Microsoft Office Suite, and foundational courses in software solutions. Cindy is highly organized, detail-oriented, and committed to delivering exceptional results in fast-paced environments. She is also skilled in communication, problem-solving, and maintaining strong relationships with clients, vendors, and partners.